Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1997-5-5
pubmed:abstractText
An in vitro study of the activity of 15 antibacterial agents against 202 recent pediatric isolates of Streptococcus pneumoniae from urban and rural Nebraska and rural Kentucky identified trovafloxacin, ofloxacin, clindamycin, and vancomycin as the most active agents and equally active against both penicillin-susceptible and--resistant strains. In contrast, six beta-lactams, three macrolides, and trimethoprim-sulfamethoxazole were less active overall, especially against penicillin-intermediate and--resistant strains. Trovafloxacin inhibited all strains at a concentration of < or = 0.25 micrograms/ml and was 8- to 16-fold more potent than ofloxacin or ciprofloxacin.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-1323956, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-1416854, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-1617079, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-3183429, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-7695281, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-7768776, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-7840581, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-7928840, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-7970944, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-8031069, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-8150756, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-8584316, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-8618188, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-8626270, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-8647777, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-8723468, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-8726030, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-8821604, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-8834881, http://linkedlifedata.com/resource/pubmed/commentcorrection/9021213-9156383
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
478-80
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae.
pubmed:affiliation
Department of Medical Microbiology and Immunology, Creighton University, School of Medicine, Omaha, Nebraska 68178, USA. kstaac@creighton.edu
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't